Sex differences of urinary and kidney globotriaosylceramide and lyso-globotriaosylceramide in Fabry mice
Authors:
- Brandon DurantBDBrandon Durant
- Sabrina ForniSFSabrina Forni
- Lawrence SweetmanLSLawrence Sweetman
- Nastry BrignolNBNastry Brignol
- Xing-Li MengXMXing-Li Meng
- Elfrida R. BenjaminEBElfrida R. Benjamin
- Raphael SchiffmannRSRaphael Schiffmann
- Jin-Song ShenJSJin-Song Shen
Open Access
- 1 September 2011
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 52 (9) , 1742-1746
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry DiseasePLOS ONE, 2010
- Increased globotriaosylceramide levels in a transgenic mouse expressing human 1,4-galactosyltransferase and a mouse model for treating Fabry diseaseThe Journal of Biochemistry, 2010
- Characterization of Fabry mice treated with recombinant adeno-associated virus 2/8-mediated gene transferJournal of Biomedical Science, 2010
- The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry DiseaseMolecular Therapy, 2010
- Fabry diseasePharmacology & Therapeutics, 2009
- Long-term inhibition of glycosphingolipid accumulation in Fabry model mice by a single systemic injection of AAV1 vector in the neonatal periodMolecular Genetics and Metabolism, 2009
- Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cellsMolecular Genetics and Metabolism, 2008
- Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry diseaseMolecular Genetics and Metabolism, 2008
- Elevated globotriaosylsphingosine is a hallmark of Fabry diseaseProceedings of the National Academy of Sciences, 2008
- Genetic control of glucuronidase induction in miceJournal of Molecular Biology, 1973